Skip to main content
Caplight Logo









Bestudy (Shanghai) Medical Technology Co., Ltd.

Bestudy (Shanghai) Medical Technology Co., Ltd.

Private
ShanghaiHealthcare & Life Scienceshttps://www.bestudycro.com/

Last Round

M&A

Mar 20, 2026

Total Funding Raised

$14.7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Bestudy (Shanghai) Medical Technology Co., Ltd. is a clinical research organization that provides integrated Phase I–IV clinical trial services, including study design, regulatory submissions, site activation, clinical operations, data management, and biostatistics for pharmaceutical and medical device companies.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Biotechnology, Medical Devices, Compliance

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

contract research organizationCROclinical trial managementclinical research servicesbiostatisticsclinical monitoringregulatory registrationsite managementmedical writingdrug development outsourcingclinical trial designpharma outsourcingclinical data managementmedical device trialsbiotech services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bestudy (Shanghai) Medical Technology Co., Ltd. Comparables

Compare Bestudy (Shanghai) Medical Technology Co., Ltd. with similar companies based on industry and business-model similarity.

Bestudy (Shanghai) Medical Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GCP ClinPlus
89%
Harvest Integrated Research Organization
88%
Panacro Pharmaceutical Technology
87%

Bestudy (Shanghai) Medical Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AMar 20, 2026
Series BSep 23, 2020

Bestudy (Shanghai) Medical Technology Co., Ltd. Investors

Notable investors and investment history

Bestudy (Shanghai) Medical Technology Co., Ltd. investors
InvestorRounds
Loyal Valley CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 20, 2026

    Syneos Health participated in the M&A round.

  • Sep 23, 2020

    $15M round led by Loyal Valley Capital

Bestudy (Shanghai) Medical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bestudy (Shanghai) Medical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bestudy (Shanghai) Medical Technology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range29
Year Founded2010
Last FundingMar 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?